Have a feature idea you'd love to see implemented?
Let us know!
NOTV Inotiv Inc
Price (delayed)
$4.22
Market cap
$109.78M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.19
Enterprise value
$533.47M
Bioanalytical Systems, Inc., operating as Inotiv, is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and
Highlights
NOTV's gross profit is down by 39% YoY and by 14% QoQ
The equity has declined by 37% year-on-year and by 6% since the previous quarter
Key stats
What are the main financial stats of NOTV
Market
Valuations
Earnings
Shares outstanding
26.02M
Market cap
$109.78M
Enterprise value
$533.47M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.64
Price to sales (P/S)
0.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.09
Revenue
$490.74M
Gross profit
$111.17M
Net income
-$108.45M
EBIT
-$83.44M
EBITDA
-$26.32M
Free cash flow
-$23.64M
Per share
Balance sheet
Liquidity
EPS
-$4.19
EPS diluted
-$4.19
Free cash flow per share
-$0.91
Book value per share
$6.56
Revenue per share
$18.95
TBVPS
$15.94
Total assets
$781.36M
Total liabilities
$610.86M
Debt
$445.12M
Equity
$170.5M
Working capital
$44.37M
Debt to equity
2.61
Current ratio
1.37
Quick ratio
0.8
Net debt/EBITDA
-16.1
Margins
Efficiency
Dividend
EBITDA margin
-5.4%
Gross margin
22.7%
Net margin
-22.1%
Operating margin
-17.6%
Return on assets
-13.5%
Return on equity
-53.3%
Return on invested capital
-15.8%
Return on capital employed
-12.6%
Return on sales
-17%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NOTV stock price
How has the Inotiv stock price performed over time
Intraday
0%
1 week
-16.6%
1 month
-29.08%
1 year
4.2%
YTD
1.93%
QTD
1.93%
Financial performance
How have Inotiv's revenue and profit performed over time
Revenue
$490.74M
Gross profit
$111.17M
Operating income
-$86.41M
Net income
-$108.45M
Gross margin
22.7%
Net margin
-22.1%
NOTV's gross profit is down by 39% YoY and by 14% QoQ
NOTV's gross margin is down by 29% year-on-year and by 12% since the previous quarter
The operating margin has decreased by 25% from the previous quarter and by 24% YoY
The operating income has declined by 22% since the previous quarter and by 6% year-on-year
Growth
What is Inotiv's growth rate over time
Valuation
What is Inotiv stock price valuation
P/E
N/A
P/B
0.64
P/S
0.22
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.09
Inotiv's EPS has decreased by 9% from the previous quarter and by 2.2% YoY
The P/B is 85% lower than the 5-year quarterly average of 4.4 but 7% higher than the last 4 quarters average of 0.6
The equity has declined by 37% year-on-year and by 6% since the previous quarter
The price to sales (P/S) is 85% less than the 5-year quarterly average of 1.5 but 10% more than the last 4 quarters average of 0.2
Inotiv's revenue has decreased by 14% YoY and by 2.1% QoQ
Efficiency
How efficient is Inotiv business performance
Inotiv's return on equity has decreased by 40% YoY and by 23% QoQ
The ROIC is down by 37% YoY and by 21% QoQ
Inotiv's ROS has decreased by 24% from the previous quarter and by 20% YoY
The ROA fell by 12% QoQ and by 11% YoY
Dividends
What is NOTV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NOTV.
Financial health
How did Inotiv financials performed over time
The total assets is 28% greater than the total liabilities
Inotiv's current ratio has decreased by 15% YoY
NOTV's quick ratio is down by 14% year-on-year
The debt is 161% more than the equity
The company's debt to equity has surged by 68% YoY and by 11% QoQ
The equity has declined by 37% year-on-year and by 6% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.